Jason Wild first joined the board as Chairman of TerrAscend after leading a private placement into the company in 2017. Having built a deep knowledge base and network in the cannabis industry over the years, Mr. Wild brings strategic value as an investor and partner. As the company’s Executive Chairman, Mr. Wild works collaboratively with the board and management team to help guide the company’s strategy and source M&A opportunities.

In addition to his role with TerrAscend, Mr. Wild is the President and Chief Investment Officer of JW Asset Management, an SEC registered investment adviser with approximately $350 million in assets under management. Starting his first fund in 1998 with under $100,000 in assets, Mr. Wild achieved early success by leveraging his background as a pharmacist finding undervalued, specialty pharmaceutical companies, and focusing on long term price appreciation.

Mr. Wild also serves on the boards of Vitruvias Therapeutics, a US based generic drug company, Carma Holdco Inc., a global house of brands with a focus on celebrity endorsements, including the Tyson 2.0 brand, which entered the cannabis market in 2021, and Allumia, Inc., a software company developing an Efficiency-as-a-Service technology platform for large-scale deployment of energy efficiency solutions.